MedTrace Logo

A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

NCT01655862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2017-03-30

No results posted yet for this study

Summary

This is an observational study to assess health-related quality of life in patients with cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice.

Conditions

  • Torticollis

Interventions

BIOLOGICAL

OnabotulinumtoxinA

OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Goran Davidovic · Allergan

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655862 on ClinicalTrials.gov